Cargando…

β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice

Globoid cell leukodystrophy (GLD), or Krabbe disease, is a neurodegenerative sphingolipidosis caused by genetic deficiency of lysosomal β-galactosylceramidase (GALC), characterized by neuroinflammation and demyelination of the central (CNS) and peripheral nervous system. The acute phase protein long...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coltrini, Daniela, Chandran, Adwaid Manu Krishna, Belleri, Mirella, Poliani, Pietro L., Cominelli, Manuela, Pagani, Francesca, Capra, Miriam, Calza, Stefano, Prioni, Simona, Mauri, Laura, Prinetti, Alessandro, Kofler, Julia K., Escolar, Maria L., Presta, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409448/ https://www.ncbi.nlm.nih.gov/pubmed/36012705 http://dx.doi.org/10.3390/ijms23169436

Ejemplares similares

β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease
por: Belleri, Mirella, et al.
Publicado: (2019)

β-Galactosylceramidase in cancer: more than a psychosine scavenger
por: Belleri, Mirella, et al.
Publicado: (2022)

Reliable and Fast Genotyping Protocol for Galactosylceramidase (Galc) in the Twitcher (Twi) Mouse
por: Carpi, Sara, et al.
Publicado: (2022)

Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease
por: Righi, Marco, et al.
Publicado: (2019)

Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease
por: Iacono, Diego, et al.
Publicado: (2022)

Visual System Impairment in a Mouse Model of Krabbe Disease: The Twitcher Mouse
por: Tonazzini, Ilaria, et al.
Publicado: (2020)

Brainstem development requires galactosylceramidase and is critical for pathogenesis in a model of Krabbe disease
por: Weinstock, Nadav I., et al.
Publicado: (2020)

Neuron-specific ablation of the Krabbe disease gene galactosylceramidase in mice results in neurodegeneration
por: Kreher, Conlan, et al.
Publicado: (2022)

Characterization of adipose-derived stromal/stem cells from the twitcher mouse model of krabbe disease
por: Zhang, Xiujuan, et al.
Publicado: (2013)

The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells
por: Capoferri, Davide, et al.
Publicado: (2023)

Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma Cells
por: Ronca, Roberto, et al.
Publicado: (2021)

Collective Dynamics of Model Pili-Based Twitcher-Mode Bacilliforms
por: Nagel, Andrew M., et al.
Publicado: (2020)

Peripheral neuropathy in the Twitcher mouse involves the activation of axonal caspase 3
por: Smith, Benjamin, et al.
Publicado: (2011)

Improved Brain Pathology and Progressive Peripheral Neuropathy in a 15 Year Old Survivor of Infantile Krabbe Disease Treated With Umbilical Cord Transplantation
por: Kofler, Julia, et al.
Publicado: (2022)

VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients
por: Rezzola, Sara, et al.
Publicado: (2021)

Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
por: Grassi, Sara, et al.
Publicado: (2019)

GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease
por: Senkevich, Konstantin, et al.
Publicado: (2022)

Regional differences in fiber tractography predict neurodevelopmental outcomes in neonates with infantile Krabbe disease
por: Gupta, A., et al.
Publicado: (2014)

Lysosomal TMEM106B interacts with galactosylceramidase to regulate myelin lipid metabolism
por: Takahashi, Hideyuki, et al.
Publicado: (2023)

Optic nerve enlargement in infantile form of Krabbe disease
por: Castilha-Neto, Dimas, et al.
Publicado: (2012)

In vitro Validation of Chimeric β-Galactosylceramidase Enzymes With Improved Enzymatic Activity and Increased Secretion
por: Ricca, Alessandra, et al.
Publicado: (2020)

Neuroimmune mechanisms in Krabbe's disease
por: Potter, Gregory B., et al.
Publicado: (2016)

Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months
por: Beltran-Quintero, Maria L., et al.
Publicado: (2019)

Pathogenic Variants in GALC Gene Correlate With Late Onset Krabbe Disease and Vision Loss: Case Series and Review of Literature
por: Bascou, Nicholas A., et al.
Publicado: (2020)

Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
por: Kagitani-Shimono, Kuriko, et al.
Publicado: (2005)

Can early treatment of twitcher mice with high dose AAVrh10-GALC eliminate the need for BMT?
por: Rafi, Mohammad A, et al.
Publicado: (2021)

FGF-trapping hampers cancer stem-like cells in uveal melanoma
por: Loda, Alessandra, et al.
Publicado: (2023)

EBF1 is expressed in pericytes and contributes to pericyte cell commitment
por: Pagani, Francesca, et al.
Publicado: (2021)

Identification of the antigen recognized by rHIgM22, a remyelination-promoting human monoclonal antibody
por: Grassi, Sara, et al.
Publicado: (2015)

Advances in the Diagnosis and Treatment of Krabbe Disease
por: Wenger, David A, et al.
Publicado: (2021)

Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2
por: Presta, Marco, et al.
Publicado: (2018)

Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion
por: Manocha, Ekta, et al.
Publicado: (2021)

A prospective natural history study of Krabbe disease in a patient cohort with onset between 6 months and 3 years of life
por: Bascou, Nicholas, et al.
Publicado: (2018)

Leptomeningeal dissemination of anaplastic medullary cone astrocytoma: an unexpected findings in a patient with leptomeningeal enhancement and clinical history of multiple myeloma
por: Daffini, Linda, et al.
Publicado: (2021)

Identification and Characterization of 15 Novel GALC Gene Mutations Causing Krabbe Disease
por: Tappino, Barbara, et al.
Publicado: (2010)

Revisiting magnetic resonance imaging pattern of Krabbe disease – Lessons from an Indian cohort
por: Muthusamy, Karthik, et al.
Publicado: (2019)

Azasugar inhibitors as pharmacological chaperones for Krabbe disease
por: Hill, Chris H., et al.
Publicado: (2015)

Gene therapy for CNS diseases – Krabbe disease
por: Rafi, Mohammad A.
Publicado: (2016)

Krabbe disease: New hope for an old disease
por: Bradbury, Allison M., et al.
Publicado: (2021)

Krabbe disease: A personal perspective and hypothesis
por: Rafi, Mohammad A.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c4rbm4643c3oc3sba1ts5li0fs